CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. According to official data, there have been ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...

Although several vaccines and drugs are available against SARS-CoV-2, the search for effective therapeutic agents for COVID-19 and future zoonotic coronaviruses continues. The RNA-dependent RNA ...

In retrospect, it is hard to avoid the conclusion that Fauci, who proclaimed, “I represent science,” purposefully lied and dissembled to conceal the funding of gain-of-function research (that makes ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

A screen of human-infecting viruses identified extensive examples of viral proteins that resembled human sequences, which ...

The following is a summary of “A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 ...

Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.